Board Meeting Outcome for The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter and Half year Ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board, at its meeting on November 14, 2025, approved the unaudited financial results for the quarter and half year ended September 30, 2025. On a standalone basis, revenue from operations fell sharply to Rs. 26.96 crore in H1 FY26 from Rs. 102.78 crore in H1 FY25, a drop of roughly 74%. Standalone profit after tax for H1 FY26 was just Rs. 20.12 lakh versus Rs. 3.15 crore in H1 FY25, a near wipe-out of prior-year earnings. Consolidated PAT for H1 FY26 was Rs. 13.27 crore, largely supported by subsidiary Remlife Global PTE (Singapore) which contributed Rs. 8.55 crore in standalone PAT for the quarter. Statutory auditors Taori Sandeep & Associates issued a clean limited review for both sets of results, but flagged that receivables, payables, loans, and advances remain subject to confirmation and reconciliation with effects that may be considerable, and noted the subsidiary's financials were not independently audited by their auditor.
Standalone business has clearly deteriorated with revenue collapsing ~74% YoY and profits nearly vanishing, which is a significant red flag for minority shareholders. The strong consolidated picture depends on a foreign subsidiary whose financials are not audited by an independent reviewer. The huge stock of unconfirmed receivables (~Rs. 565 crore) and loans/advances (~Rs. 685 crore) on the standalone books remains a material risk to reported earnings and asset values.